Lipocine Inc. (LPCN) - Stock Prices, Stock Peers & Analysis

Home
LPCN

Company Name	Lipocine Inc.
Symbol	LPCN
Currency	USD
Price	3.66
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	19,573,460
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	2.31 - 11.79
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Mahesh V. Patel Ph.D.
Website	https://www.lipocine.com

An error occurred while fetching data.

About Lipocine Inc.

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline